# Sustained abnormal bilirubin and leukocyte levels after ERCP with acute suppurative obstructive cholangitis: a case report with 2 months follow-up observation

**Authors:** Jie Zheng, Jiahao Mo, Jintang Xiong, Jiaming He, Lu Wang, Yan Chen

PMC · DOI: 10.3389/fimmu.2026.1726277 · 2026-03-16

## TL;DR

A patient had ongoing high bilirubin and white blood cell levels after ERCP, which were eventually linked to a liver fluke infection.

## Contribution

Highlights the role of eosinophilia in diagnosing parasitic infections after ERCP when standard tests are negative.

## Key findings

- Persistent hyperbilirubinemia and leukocytosis after ERCP were linked to an undiagnosed liver fluke infection.
- Diagnostic treatment with albendazole led to normalization of blood markers.
- Liver fluke detection in ENBD fluid and positive IgG confirmed the diagnosis.

## Abstract

Acute Suppurative Obstructive Cholangitis (AOSC) typically resolves post-ERCP. However, a 53-year-old male had persistent hyperbilirubinemia and leukocytosis (WBC 28.12×109/L) along with marked eosinophilia (20.26×109/L) despite standard antibiotic therapy. Systematic diagnosis ruled out residual calculi, Endoscopic Nasobiliary Drainage (ENBD) dysfunction, biliary neoplasms, and sclerosing cholangitis. A history of undercooked freshwater fish consumption and eosinophilia prompted suspicion of occult liver fluke infection, despite negative initial stool tests. Diagnostic treatment with albendazole resulted in a decrease in WBC and eosinophil counts; subsequent detection of liver flukes in ENBD fluid and positive liver fluke IgG confirmed the diagnosis. At 2-month follow-up, all markers normalized. This case highlights the diagnostic value of eosinophilia in guiding the identification of parasitic infections in refractory post-ERCP inflammation, and the utility of diagnostic therapy when direct evidence is lacking.

## Linked entities

- **Chemicals:** albendazole (PubChem CID 2082)

## Full-text entities

- **Diseases:** leukocytosis (MESH:D007964), biliary neoplasms (MESH:D001661), hyperbilirubinemia (MESH:D006932), AOSC (MESH:D013969), ENBD) dysfunction (MESH:D065634), Suppurative Obstructive Cholangitis (MESH:D002761), parasitic infections (MESH:D010272), sclerosing cholangitis (MESH:D015209), calculi (MESH:D002137), liver fluke (MESH:D017093), eosinophilia (MESH:D004802), inflammation (MESH:D007249)
- **Chemicals:** albendazole (MESH:D015766), bilirubin (MESH:D001663)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13033484/full.md

---
Source: https://tomesphere.com/paper/PMC13033484